10-120851486-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_018117.12(WDR11):​c.66C>G​(p.His22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000813 in 1,611,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H22P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

WDR11
NM_018117.12 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.71

Publications

0 publications found
Variant links:
Genes affected
WDR11 (HGNC:13831): (WD repeat domain 11) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008]
WDR11-DT (HGNC:27437): (WDR11 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016449034).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000473 (72/152354) while in subpopulation AFR AF = 0.00168 (70/41588). AF 95% confidence interval is 0.00137. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR11NM_018117.12 linkc.66C>G p.His22Gln missense_variant Exon 1 of 29 ENST00000263461.11 NP_060587.8 Q9BZH6
WDR11XR_007061973.1 linkn.125C>G non_coding_transcript_exon_variant Exon 1 of 20
WDR11XR_428707.4 linkn.125C>G non_coding_transcript_exon_variant Exon 1 of 28
WDR11XM_005269963.3 linkc.-733C>G 5_prime_UTR_variant Exon 1 of 29 XP_005270020.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR11ENST00000263461.11 linkc.66C>G p.His22Gln missense_variant Exon 1 of 29 1 NM_018117.12 ENSP00000263461.5 Q9BZH6
WDR11ENST00000605543.5 linkn.66C>G non_coding_transcript_exon_variant Exon 1 of 22 2 ENSP00000475076.1 S4R451

Frequencies

GnomAD3 genomes
AF:
0.000460
AC:
70
AN:
152236
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000995
AC:
24
AN:
241308
AF XY:
0.0000911
show subpopulations
Gnomad AFR exome
AF:
0.00127
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000930
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000404
AC:
59
AN:
1459634
Hom.:
0
Cov.:
31
AF XY:
0.0000441
AC XY:
32
AN XY:
725926
show subpopulations
African (AFR)
AF:
0.00129
AC:
43
AN:
33460
American (AMR)
AF:
0.000112
AC:
5
AN:
44572
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26068
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39650
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52460
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1111646
Other (OTH)
AF:
0.0000829
AC:
5
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152354
Hom.:
0
Cov.:
33
AF XY:
0.000483
AC XY:
36
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00168
AC:
70
AN:
41588
American (AMR)
AF:
0.0000653
AC:
1
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000252
Hom.:
0
Bravo
AF:
0.000559
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000907
AC:
11
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Oct 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces histidine, which is basic and polar, with glutamine, which is neutral and polar, at codon 22 of the WDR11 protein (p.His22Gln). This variant is present in population databases (rs138044064, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with WDR11-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
21
DANN
Benign
0.89
DEOGEN2
Benign
0.043
T
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.73
T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.57
T
MutationAssessor
Benign
-0.97
N
PhyloP100
1.7
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
1.2
N
REVEL
Benign
0.26
Sift
Benign
0.83
T
Sift4G
Benign
0.64
T
Polyphen
0.0
B
Vest4
0.083
MutPred
0.41
Gain of catalytic residue at H22 (P = 0.0025);
MVP
0.62
MPC
0.31
ClinPred
0.055
T
GERP RS
4.6
PromoterAI
0.061
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.23
gMVP
0.51
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138044064; hg19: chr10-122610998; API